Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients

@article{Fogari2007EffectOV,
  title={Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients},
  author={Roberto Fogari and Annalisa Zoppi and Giuseppe Derosa and Amedeo Mugellini and Pierangelo Lazzari and Andrea Rinaldi and Elena Fogari and Paola Preti},
  journal={Journal of Human Hypertension},
  year={2007},
  volume={21},
  pages={220-224}
}
The aim of this study was to assess the effect of valsartan addition to amlodipine on ankle foot volume (AFV) and pretibial subcutaneous tissue pressure (PSTP), two objective measures of ankle oedema. After a 4-week placebo period, 80 grade 1–2 hypertensive patients (diastolic blood pressure (DBP)>90 mm Hg and <110 systolic blood pressure (SBP)>140 mm Hg) were randomized to amlodipine 10 mg or valsartan 160 mg or amlodipine 10 mg plus valsartan 160 mg for 6 weeks according to an open-label… CONTINUE READING

3 Figures & Tables

Connections & Topics

Mentioned Connections BETA
Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients .
Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients .
Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients .
Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients .
Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients .
After a 4-week placebo period , 80 grade 1–2 hypertensive patients ( diastolic blood pressure ( DBP)>90 mm Hg and < 110 systolic blood pressure ( SBP)>140 mm Hg ) were randomized to amlodipine 10 mg or valsartan 160 mg or amlodipine 10 mg plus valsartan 160 mg for 6 weeks according to an open - label , blinded end point , crossover design .
After a 4-week placebo period , 80 grade 1–2 hypertensive patients ( diastolic blood pressure ( DBP)>90 mm Hg and < 110 systolic blood pressure ( SBP)>140 mm Hg ) were randomized to amlodipine 10 mg or valsartan 160 mg or amlodipine 10 mg plus valsartan 160 mg for 6 weeks according to an open - label , blinded end point , crossover design .
Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients .
After a 4-week placebo period , 80 grade 1–2 hypertensive patients ( diastolic blood pressure ( DBP)>90 mm Hg and < 110 systolic blood pressure ( SBP)>140 mm Hg ) were randomized to amlodipine 10 mg or valsartan 160 mg or amlodipine 10 mg plus valsartan 160 mg for 6 weeks according to an open - label , blinded end point , crossover design .
After a 4-week placebo period , 80 grade 1–2 hypertensive patients ( diastolic blood pressure ( DBP)>90 mm Hg and < 110 systolic blood pressure ( SBP)>140 mm Hg ) were randomized to amlodipine 10 mg or valsartan 160 mg or amlodipine 10 mg plus valsartan 160 mg for 6 weeks according to an open - label , blinded end point , crossover design .
All Topics